Cantor Fitzgerald Initiates StemCells With Buy

By: via Benzinga
Analysts at Cantor Fitzgerald initiated coverage on StemCells Inc (NASDAQ: STEM) with a Buy rating. The target price for StemCells is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.